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Abstract 
Cardiac surgical procedures are among the most complex operations with a 
detailed list of perioperative care. Weaning from CPB is associated with a 
number of disturbances in cardiac rhythm. One of the most challenging cardiac 
rhythm disturbances is the ventricular arrhythmia (tachycardia/fibrillation). 
Cardioversion and antiarrhythmic agents may be ineffective after aortic 
declamping; systemic hyperkalemia may be a therapeutic option. Here, we 
review the available studies regarding this issue and the possible underlying 
mechanisms of this therapeutic approach. 
Keywords: Electrophysiological Refractory Period; Arrhythmia; Hyperkalemia 
 
Please cite this article as: Dabbagh A, Foroughi M, Imani A. Induced Therapeutic 
Hyperkalemia as a Method for Treatment of Refractory Arrhythmias after Aortic Declamping 
in Cardiac Surgical Procedures: A Narrative Review. J Cell Mol Anesth. 2019;4(3):96-9.  
 
Introduction 
Cardiac surgical procedures are among the most 
complex procedures with a detailed list of 
perioperative care. One of the main procedures during 
cardiac surgery is the cardiopulmonary bypass (CPB); 
mandating a series of sophisticated tasks to be done in 
an appropriate order. However, CPB has its own 
disadvantages and events; weaning from CPB is 
among them and highly depends on the adequacy of 
different parameters including cardiac contractility, 
temperature, cardiac rhythm, and arterial blood gas. 
The most frequent disturbances in cardiac rhythm may 
be attributed to electrolyte imbalance, mechanical 
injury to conductive tissues, defect in myocardial 
preservation, ischemic reperfusion injury, and other 
cellular mechanisms. As teamwork, the surgeon and 
cardiac anesthesiologist should evaluate these 
differential diagnoses and rule out the possible 
etiologies one by one, as the treatment of each cause 
may be completely different from others. One of the 
most challenging rhythm disturbances is the 
ventricular arrhythmia (tachycardia/ fibrillation) in the 
ischemic-reperfusion setting. The commonly used 
approaches include cardioversion and a number of 
anti-arrhythmic agents; electrical cardioversion may 
lead to minor myocardial injury or dysfunction (1, 2); 
which is a challenge in daily practice in patients with 
underlying cardiac disease (3-5). What should be done 
if there is no response to these classic interventions 
while the patient is on CPB and usually, the adequate 
perfusion provided by the CPB machine, relieves our 
concerns about potential organ hypoperfusion; 
including the CNS?  
Here, we reviewed the studies considering 
therapeutic hyperkalemia as the method for treatment 
of refractory arrhythmias (VT storm) occurring after 
aortic de-clamping until weaning from CPB. 
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Discussion 
Successful treatment of ventricular fibrillation 
through direct use of potassium (K) into the heart 
chamber has been reported as early as 1961; it was an 
anecdotal case report during inguinal hernia repair in a 
3 years old Babyboy (6). In 1979, Lazar, et al. 
performed an animal study on 20 samples and 
concluded that using a small dose of continuous blood 
cardioplegia leading to re-arrest of the heart leads to 
better outcomes in the reversal of VT storm, needing 
less consumption of energy for ventricular 
defibrillation (7). 
In another experimental study, Marill et al 
studied the role of chemical defibrillation as an 
alternative approach for the treatment of intra-arrest 
VF waveform. They concluded that potassium 
supplemented by calcium (administered in their study 
as KCl+CaCl2) leads to results comparable with 
standard therapy regarding the return of spontaneous 
circulation (ROSC) and "post-ROSC hemodynamics" 
(8). 
Yang et al, demonstrated an experimental model 
of resuscitation after cardiac arrest in rats, in which 
hyperkalemia could exert the following 4 results (9): 
• promoted enlargement of the VF amplitude  
• expedited spontaneous conversion 
• raised the rate of successful defibrillation 
• decreased the needed energy for VF 
defibrillation 
In 1984, Robicsek reported a technique of re-
clamping and infusing 37°C cardioplegia until 
reaching standstill; then pacing and returning to a 
normal rhythm in refractory ventricular tachycardia 
(10). In 1995, Ovrum, et al. reported a case series of 
200 cardiac surgical patients in two groups (100 in 
each); one group has received 20 mEq of KCl into the 
aortic root and the other did not receive it. The result 
was the significant decreased need to use electrical 
energy for the treatment of post-declamping 
ventricular arrhythmias (11). Watanabe and colleagues 
injected a high concentration of 20 mEq KCl into the 
root of the aorta to treat refractory VF; they did this 
technique in 3 valve surgery patients after declamping 
of the aorta and needed no defibrillation in order to 
resolve sinus rhythm (12). Turkoz, et al. reported 
secondary cross-clamping added with an infusion of an 
extra dose of cardioplegia to treat VT storm (13, 14). 
Gadhinglajkar, et al. reported similar results regarding 
the use of warm cardioplegia into the root of the aorta 
in 3 adult patients undergoing aortic valve replacement 
surgery (15). In a clinical study on 8465 adult patients 
undergoing cardiac surgery patients with CPB, all the 
study patients having VF after declamping of aorta 
received potassium infusion (20 mmol plus an extra 10 
mmol if needed). The patients in this study had a low 
rate of direct countershock and compared with other 
patient groups, had a lower rate of demand for pacing 
during weaning from bypass; the results suggested 
potassium infusion as an "effective and convenient 
first-hand measure" in treatment of post declamping 
VF in cardiac surgery patients undergoing CPB (16). 
Underlying Mechanism 
Refractory arrhythmia after CPB is a main 
clinical problem, which could be considered as a sign 
of an underlying imbalance in myocardial action 
potentials. In fact, during cardiac surgery with CPB, 
the infusion of cardioplegia to the root of the aorta is a 
common and long-lived practice, leading to Diastolic 
arrest, protect the myocardium, prepare motionless and 
bloodless field to facilitates meticulous operation (17); 
however, this approach leads to an abnormal imbalance 
in normal resting and action potential of myocardial 
cells. After the reinstitution of normal rhythm due to 
the vanished effects of cardioplegia, the ischemia-
reperfusion effects are added to the cardioplegia-
induced electrolyte imbalance (18-20). Nevertheless, 
how could we explain the antiarrhythmic effects of 
extra KCl doses?  
One may consider the effects of adding extra 
KCl simply as an asystole-inducing agent; leading to 
asystole and after the normal action potential is 
reinstituted, the normal sinus rhythm initiates 
spontaneously (21). Though this seems a plausible 
explanation, there might be other underlying 
mechanisms. One main mechanism is the effects of 
potassium inward rectifying channels (KIR) on cardiac 
arrhythmias (22, 23). KIR channels constitute a simple 
but diverse ion channel superfamily of 7 subtypes (24). 
The first KIR has been cloned in 1993 (25); but 
research in this field is still awaiting novel and 
surprising results, especially in the field of cardiac 
excitability (26). Though they are found in a number of 
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organ tissues, KIR2, KIR3, and KIR6 are the cardiac-
specific subtypes (23, 27, 28). Ventricular KIR 
channels have an important role in cardioprotection 
during ischemic preconditioning and in shortening of 
action potential during ischemia-reperfusion periods 
(29, 30). There are new perspectives for potential drug 
effects on myocardial KIR channels (31), which could 
be one of the main possible explanations for the 
antiarrhythmic effects of hyperkalemia inducing 
asystole after declamping of patients and treatment of 
refractory ventricular tachycardia.  
In summary, the main electrophysiological 
effects of systemic hyperkalemia could be categorized 
under these three items (32): 
• depolarization of resting membrane potential 
(Em) via less negative values of the Nernst 
equilibrium potential for K+ (EK) 
• shortening of action potential duration 
• changes in conduction velocity  
Through increasing K+ channel conductance 
and inducing post-repolarization refractoriness, 
hyperkalemia can prolong the effective refractory 
period. Since activation and inactivation states of the 
Na+ fast channels depend on [K+]o magnitude, 
hyperkalemia induces biphasic effects on conduction 
velocity. In other words, it is increased at lower [K+]o 
(up to 8 mmol/L) and reduced at higher [K+]o levels 
(32). 
Conclusion 
Our proposed strategy was to create systemic 
hyperkalemia with or without inducing hypothermia. 
Infusion of high dose KCL (20 mEq) induces cardiac 
diastolic arrest and relief of ventricular arrhythmia. 
Once the cardiac arrest is well established, 
conventional ultrafiltration should be restored in such 
a way that hyperkalemia would be corrected gradually. 
The sinus normal rhythm appears in most of the 
patients; though other supportive considerations 
should be available like any other routine patient; 
including drips of antiarrhythmic agents; cardioverter 
defibrillator, and even, heart mechanical support such 
as intra-aortic balloon pump.  
The systemic hyperkalemia is a known and 
relatively routine strategy for myocardial protection in 
redo surgeries with patent LIMA (left internal 
mammary artery) anastomosis in order to avoid 
manipulation around the LIMA area, as its damage 
would be associated with significant mortality. The 
disadvantage of this method is prolonging CPB time to 
remove the excess concentration of K from serum. 
Nevertheless, when there is no response to 
conventional treatment modalities, it could be the 
unique magic option. 
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